FDA
approval
· 2023-05-25
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approves Amneal Pharmaceuticals LLC's supplemental application for a generic buprenorphine HCl and naloxone HCl product for the treatment of opioid use diso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)